N Engl J Med 2022 Nov 03
Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas.   

Related Questions


Specifically, would you consider either neoadjuvant or adjuvant immunotherapy in this setting, or only after recurrence?